Pharma & HealthcareAvoid

ITI Pharma And Healthcare

ITI · Direct–Growth · rank #18 of 18 by Smart Score

Trailing returns

vs Nifty 500 (index-fund proxy)

1 Year

5.6%

+5.0% vs index

3 Years

20.7%

+8.5% vs index

5 Years

—

Since launch

14.9%

last entry = YTD

2022

-6.7%-10.5% vs index

2023

+34.4%+7.9% vs index

2024

+44.0%+28.3% vs index

2025

-8.2%-15.9% vs index

2026

+12.3%+14.1% vs index

ITI Pharma And Healthcare scores 21/100 — #18 of 18 Pharma & Healthcare fund (Avoid). The main drag is its 3y return (better than only 5% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

3Y return20.67% · 5th percentile in category

Alpha0.25 · 3rd percentile in category

Fund size251.87 Cr · 14th percentile in category

Sharpe ratio0.95 · 26th percentile in category

1Y return5.56% · 3rd percentile in category

Volatility16.83 · 26th percentile in category